Brief: Monte Rosa Therapeutics Reports Third Quarter Results
10/11/2022 13:07
Nov 10 (Reuters) - Monte Rosa Therapeutics Inc GLUE.O :
* MONTE ROSA THERAPEUTICS REPORTS THIRD QUARTER 2022
FINANCIAL
RESULTS AND BUSINESS UPDATES
* MONTE ROSA THERAPEUTICS - EXPECTS ITS CASH AND CASH
EQUIVALENTS
WILL BE SUFFICIENT TO FUND PLANNED OPERATIONS AND CAPITAL
EXPENDITURES INTO LATE 2024
* MONTE ROSA THERAPEUTICS INC QTRLY NET LOSS PER SHARE
ATTRIBUTABLE TO COMMON STOCKHOLDERS-BASIC AND DILUTED $0.58
Source text for Eikon: ID:nGNX1VD9KB
Further company coverage: GLUE.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Monte Rosa Therapeutics
See all newsBrief: Monte Rosa Therapeutics Announces Positive Results For Mrt-8102 In Gforce-1 Phase 1 Study Showing Normalization Of Key Pathogenic Drivers Of Ascvd In Subjects With Elevated Cvd Risk
Brief: Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Monte Rosa Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Monte Rosa Therapeutics Q2 revenue drops, net loss widens on higher R&D
Brief: Monte Rosa Therapeutics Q2 Collaboration Revenue USD 8.968 Million